PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
72.32
Similar ESG score to INKT's 68.97. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
76.69
Environmental score exceeding 1.2x INKT's 59.45. Mohnish Pabrai would examine if this environmental advantage creates sustainable cost advantages.
73.77
Similar social score to INKT's 76.83. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
66.49
Governance score 90-95% of INKT's 70.64. Bill Ackman would demand clear governance improvement catalysts.